Endocrine disruptors differently influence estrogen receptor β and androgen receptor in male and female rat VSMC

Journal of Cellular Physiology

Volumn 229, Issue 8, 2014, Pages 1061-1068

  Pellegrini, Marco ^a   Bulzomi, Pamela ^a   Lecis, Marco ^a   Leone, Stefano ^a   Campesi, Ilaria ^b   Franconi, Flavia ^b   Marino, Maria ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANDROGEN RECEPTOR; ANDROSTANOLONE; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; NARINGENIN; TESTOSTERONE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; BENZHYDRYL COMPOUNDS; CELLS, CULTURED; ENDOCRINE DISRUPTORS; ESTROGEN RECEPTOR BETA; FEMALE; FLAVANONES; GENE EXPRESSION REGULATION; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOLS; RATS; RECEPTORS, ANDROGEN;

EID: 84899106679     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24530     Document Type: Article

References (66)

1. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M, Marino M. 2005. Survival versus apoptotic 17 beta-estradiol effect: Role of ER alpha and ER beta activated non-genornic signaling. J Cell Physiol 203:193-201.
2. Ascenzi P, Bocedi A, Marino M. 2006. Structure-function relationship of estrogen receptor alpha and beta: Impact on human health. Mol Aspects Med 27:299-402.
3. Bain J. 2010. Testosterone and the aging male: To treat or not to treat? Maturitas 66:16-22.
4. Bergman A, Heindel JJ, Kasten T, Kidd KA, Jobling S, Neira M, Zoeller RT, Becher G, Bjerregaard P, Bornman R, Brandt I, Kortenkamp A, Muir D, Drisse MN, Ochieng R, Skakkebaek NE, Bylehn AS, Iguchi T, Toppari J, Woodruff TJ. 2013. The impact of endocrine disruption: A consensus statement on the state of the science. Environ Health Perspect 121:A104-A106.
5. Bolli A, Galluzzo P, Ascenzi P, Del Pozzo G, Manco I, Vietri MT, Mita L, Altucci L, Mita DG, Marino M. 2008. Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor alpha-dependent rapid signals. IUBMB Life 60:843-852.
6. Bolli A, Bulzomi P, Galluzzo P, Acconcia F, Marino M. 2010. Bisphenol A impairs estradiol-induced protective effects against DLD-1 colon cancer cell growth. IUBMB Life 62:684-687.
7. Bulzomi P, Marino M. 2011. Environmental endocrine disruptors: Does a sex-related susceptibility exist? Front Biosci 16:2478-2498.
8. Bulzomi P, Bolli A, Galluzzo P, Acconcia F, Ascenzi P, Marino M. 2012a. The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background. IUBMB Life 64:690-696.
9. Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, Marino M. 2012b. The pro-apoptotic effect of quercetin in cancer cell lines requires ERbeta-dependent signals. J Cell Physiol 227:1891-1898.
10. Burke AP, Farb A, Malcom G, Virmani R. 2001. Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis. Am Heart J 141:S58-S62.
11. Burns KA, Korach KS. 2012. Estrogen receptors and human disease: An update. Arch Toxicol 86:1491-1504.
12. Campelo AE, Cutini PH, Massheimer VL. 2012. Cellular actions of testosterone in vascular cells: Mechanism independent of aromatization to estradiol. Steroids 77:1033-1040.
13. Cutini PH, Campelo AE, Agriello E, Sandoval MJ, Rauschemberger MB, Massheimer VL. 2012. The role of sex steroids on cellular events involved in vascular disease. J Steroid Biochem Mol Biol 132:322-330.
14. Dai-Do D, Espinosa E, Liu G, Rabelink TJ, Julmy F, Yang Z, Mahler F, Luscher TF. 1996. 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: Similar effects in cells from postmenopausal females and in males. Cardiovasc Res 32:980-985.
15. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. 2009. Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr Rev 30:293-342.
16. Favre J, Gao J, Henry JP, Remy-Jouet I, Fourquaux I, Billon-Gales A, Thuillez C, Arnal JF, Lenfant F, Richard V. 2010. Endothelial estrogen receptor α plays an essential role in the coronary and myocardial protective effects of estradiol in ischemia/reperfusion. Arterioscler Thromb Vasc Biol 30:2562-2567.
17. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P. 2007. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148:3236-3245.
18. Fujimoto T, Kubo K, Aou S. 2006. Prenatal exposure to bisphenol A impairs sexual differentiation of exploratory behavior and increases depression-like behavior in rats. Brain Res 1068:49-55.
19. Galluzzo P, Caiazza F, Moreno S, Marino M. 2007. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr-Relat Cancer 14:153-167.
20. Galluzzo P, Ascenzi P, Bulzomi P, Marino M. 2008. The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation. Endocrinology 149:2567-2575.
21. Galluzzo P, Rastelli C, Bulzomi P, Acconcia F, Pallottini V, Marino M. 2009. 17 β-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-alpha-mediated signals. Am J Physiol-Cell Physiol 297:C1249-C1262.
22. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, Heigl A, Lachat M, Genoni M, Barton M. 2007. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 49:1358-1363.
23. Haines CD, Harvey PA, Luczak ED, Barthel KK, Konhilas JP, Watson PA, Stauffer BL, Leinwand LA. 2012. Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology 153:4470-4479.
24. Ho HH, Hsu LS, Chan KC, Chen HM, Wu CH, Wang CJ. 2010. Extract from the leaf of nucifera reduced the development of atherosclerosis via inhibition of vascular smooth muscle cell proliferation and migration. Food Chem Toxicol 48:159-168.
25. Hogg ME, Varu VN, Vavra AK, Popowich DA, Banerjee MN, Martinez J, Jiang Q, Saavedra JE, Keefer LK, Kibbe MR. 2011. Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status. Free Radic Biol Med 50:1065-1074.
26. Hogg ME, Vavra AK, Banerjee MN, Martinez J, Jiang Q, Keefer LK, Chambon P, Kibbe MR. 2012. The role of estrogen receptor alpha and beta in regulating vascular smooth muscle cell proliferation is based on sex. J Surg Res 173:e1-e10.
27. Holm A, Baldetorp B, Olde B, Leeb-Lundberg LM, Nilsson BO. 2011. The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J Vasc Res 48:327-335.
28. ++ handling. J Vasc Res 50:421-429.
29. Isensee J, Meoli L, Zazzu V, Nabzdyk C, Witt H, Soewarto D, Effertz K, Fuchs H, Gailus-Durner V, Busch D, Adler T, de Angelis MH, Irgang M, Otto C, Noppinger PR. 2009. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 150:1722-1730.
30. Jin H, Wang DY, Mei YF, Qiu WB, Zhou Y, Wang DM, Tan XR, Li YG. 2010. Mitogen-activated protein kinases pathway is involved in physiological testosterone-induced tissue factor pathway inhibitor expression in endothelial cells. Blood Coagul Fibrinolysis 21:420-424.
31. Jones BA, Watson NV. 2012. Perinatal BPA exposure demasculinizes males in measures of affect but has no effect on water maze learning in adulthood. Horm Behav 61:605-610.
32. Kappert K, Caglayan E, Huntgeburth M, Baumer AT, Sparwel J, Uebel M, Rosenkranz S. 2006. 17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. Am J Physiol-Heart Circ Physiol 290:H538-H546.
33. Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME. 2001. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res 89:534-539.
34. Kruger T, Long M, Bonefeld-Jorgensen EC. 2008. Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. Toxicology 246:112-123.
35. Lee HJ, Chattopadhyay S, Gong EY, Ahn RS, Lee K. 2003. Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicol Sci 75:40-46.
36. Lee JJ, Yi H, Kim IS, Kim Y, Nhiem NX, Kim YH, Myung CS. 2012. (2S)-naringenin from Typha angustata inhibits vascular smooth muscle cell proliferation via a G0/G1 arrest. J Ethnopharmacol 139:873-878.
37. Li G, Chen YF, Greene GL, Oparil S, Thompson JA. 1999. Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro. Circulation 100:1639-1645.
38. Malorni W, Straface E, Matarrese P, Ascione B, Coinu R, Canu S, Galluzzo P, Marino M, Franconi F. 2008. Redox state and gender differences in vascular smooth muscle cells. FEBS Lett 582:635-642.
39. Marino M, Masella R, Bulzomi P, Campesi I, Malorni W, Franconi F. 2011. Nutrition and human health from a sex-gender perspective. Mol Aspects Med 32:1-70.
40. Marino M, Pellegrini M, La Rosa P, Acconcia F. 2012. Susceptibility of estrogen receptor rapid responses to xenoestrogens: Physiological outcomes. Steroids 77:910-917.
41. Matsushima A, Liu X, Okada H, Shimohigashi M, Shimohigashi Y. 2010. Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta. Environ Health Perspect 118:1267-1272.
42. Melzer D, Osborne NJ, Henley WE, Cipelli R, Young A, Money C, McCormack P, Luben R, Khaw KT, Wareham NJ, Galloway TS. 2012. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 125:1482-1490.
43. Miller VM. 2010. Sex-based differences in vascular function. Womens Health (Lond Engl) 6:737-752.
44. Montague CR, Hunter MG, Gavrilin MA, Phillips GS, Goldschmidt-Clermont PJ, Marsh CB. 2006. Activation of estrogen receptor-alpha reduces aortic smooth muscle differentiation. Circ Res 99:477-484.
45. Moore LL. 2011. Functional foods and cardiovascular disease risk: Building the evidence base. Curr Opin Endocrinol Diabetes Obes 18:332-335.
46. Moore RJ, Jackson KG, Minihane AM. 2009. Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr 102:1790-1802.
47. Moriarty K, Kim KH, Bender JR. 2006. Minireview: Estrogen receptor-mediated rapid signaling. Endocrinology 147:5557-5563.
48. Nigro N, Christ-Crain M. 2012. Testosterone treatment in the aging male: Myth or reality? Swiss Med Wkly 142:w13539.
49. Okubo T, Urabe M, Tsuchiya H, Iwasa K, Yokota K, Kikuchi N, Yamamoto T, Honjo H. 2000. Effect of estrogen and progesterone on gene expression of growth regulatory molecules and proto-oncogene in vascular smooth muscle cells. Endocr J 47:205-214.
50. Oparil S, Levine RL, Chen SJ, Durand J, Chen YF. 1997. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulation 95:1301-1307.
51. Ostadal B, Netuka I, Maly J, Besik J, Ostadalova I. 2009. Gender differences in cardiac ischemic injury and protection-experimental aspects. Exp Biol Med (Maywood) 234:1011-1019.
52. Palanza P, Gioiosa L, vom Saal FS, Parmigiani S. 2008. Effects of developmental exposure to bisphenol A on brain and behavior in mice. Environ Res 108:150-157.
53. Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T, Cox J, Ghali WA, Grace S, Hamet P, Ho T, Kirkland S, Lambert M, Libersan D, O'Loughlin J, Paradis G, Petrovich M, Tagalakis V. 2007. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 176:S1-S44.
54. Pirwany IR, Sattar N, Greer IA, Packard CJ, Fleming R. 2002. Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles. Hum Reprod 17:825-829.
55. Register TC, Adams MR. 1998. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. J Steroid Biochem Mol Biol 64:187-191.
56. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. 2005. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630.
57. Shankar A, Teppala S. 2012. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J Environ Public Health 2012:481641.
58. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A. 1996. Adventitial remodeling after coronary arterial injury. Circulation 93:340-348.
59. Straface E, Vona R, Gambardella L, Ascione B, Marino M, Bulzomi P, Canu S, Coinu R, Rosano G, Malorni W, Franconi F. 2009. Cell sex determines anoikis resistance in vascular smooth muscle cells. FEBS Lett 583:3448-3454.
60. Villar IC, Scotland RS, Khambata RS, Chan M, Duchene J, Sampaio AL, Perretti M, Hobbs AJ, Ahluwalia A. 2011. Suppression of endothelial P-selectin expression contributes to reduced cell trafficking in females: An effect independent of NO and prostacyclin. Arterioscler Thromb Vasc Biol 31:1075-1083.
61. Visioli F, Davalos A. 2011. Polyphenols and cardiovascular disease: A critical summary of the evidence. Mini Rev Med Chem 11:1186-1190.
62. Vornehm ND, Wang M, Abarbanell A, Herrmann J, Weil B, Tan J, Wang Y, Kelly M, Meldrum DR. 2009. Acute postischemic treatment with estrogen receptor-alpha agonist or estrogen receptor-beta agonist improves myocardial recovery. Surgery 146:145-154.
63. Wetherill YB, Petre CE, Monk KR, Puga A, Knudsen KE. 2002. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells. Mol Cancer Ther 1:515-524.
64. Xi W, Wan HT, Zhao YG, Wong MH, Giesy JP, Wong CK. 2011. Effects of perinatal exposure to bisphenol A and di(2-ethylhexyl)-phthalate on gonadal development of male mice. Environ Sci Pollut Res Int 19:2515-2527.
65. Xu ZR, Hu L, Cheng LF, Qian Y, Yang YM. 2010. Dihydrotestosterone protects human vascular endothelial cells from H(2)O(2)-induced apoptosis through inhibition of caspase-3, caspase-9 and p38 MAPK. Eur J Pharmacol 643:254-259.
66. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ, Vom Saal FS. 2012. Endocrine-disrupting chemicals and public health protection: A statement of principles from the Endocrine Society. Endocrinology 153:4097-4110.